The burden of neuropathic pain: Results from a cross-sectional survey

European Journal of Pain

Volumn 10, Issue 2, 2006, Pages 127-

  McDermott, Anne M ^a   Toelle, Thomas R ^b   Rowbotham, David J ^c   Schaefer, Caroline P ^a   Dukes, Ellen M ^d  

^a Health Economics and Outcomes Research   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

Health status; Neuralgia; Neuropathic pain; Neuropathic pain management; Pain assessment

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; AZEPINE DERIVATIVE; BENZODIAZEPINE; BUSPIRONE; CARBAMAZEPINE; CYCLOOXYGENASE 2 INHIBITOR; GABAPENTIN; HERBACEOUS AGENT; HYPNOTIC AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SEDATIVE AGENT; TRAMADOL; VITAMIN;

ADULT; ANALYSIS OF VARIANCE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMPLOYMENT; EUROPE; EVALUATION; EXERCISE; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; REVIEW; SCORING SYSTEM;

EID: 28444495517     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2005.01.014     Document Type: Article

References (28)

1. G. Andersen, K. Vestergaard, M. Ingeman-Nielsen, and T. Jensen Incidence of central post-stroke pain Pain 61 1995 187 193
2. M. Backonja Use of anticonvulsants for treatment of neuropathic pain Neurology 59 Suppl. 2 2002 S14 S17
3. M. Backonja, A. Beydoun, K. Edwards, S. Schwartz, V. Fonseca, and M. Hes Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus JAMA 280 1998 1831 1836
4. Brooks and EuroQol Group EuroQol: the current state of play Health Policy 37 1996 53 72
5. C. Cleeland, and K. Ryan Pain assessment: global use of the Brief Pain Inventory Ann Acad Med 23 1994 129 138
6. R. Daut, C. Cleeland, and R. Flanery Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases Pain 17 1983 197 210
7. P. Dolan Modeling valuations for EuroQol health states Med Care 35 11 1997 1095 1108
8. R. Dworkin An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms Clin J Pain 18 2002 343 349
9. R. Dworkin, M. Backonja, M. Rowbotham, R. Allen, C. Argoff, and G. Bennett Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations Arch Neurol 60 2003 1524 1534
10. EuroQol Group EuroQol: a new facility for the measurement of health related quality of life Health Policy 16 1990 199 208
11. N. Finnerup, I. Johannesen, S. Sindrup, F. Back, and T. Jensen Pain and dysesthesia in patients with spinal cord injury: a postal survey Spinal Cord 39 2001 256 262
12. B. Galer, A. Gianas, and M. Jensen Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life Diabetes Res Clin Prac 47 2000 123 128
13. B.S. Galer, C. Keran, and M. Frisinger Pain medicine education among American neurologists: a need for improvement Neurology 52 8 1999 1710 1712
14. B.S. Galer, E. Sheldon, and N. Patel Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis Curr Med Res Opin 20 9 2004 1455 1458
15. F.J. Gilbert, A.M. Grant, and M.G.C. Gillan Low back pain: influence of early MR imaging or CT scan on treatment and outcome - multicenter randomized trial Radiology 231 2004 343 351
16. C. Kitt, K. Gruber, M. Davis, C. Woolf, and J. Levine Trigeminal neuralgia: opportunities for research and treatment Pain 85 2000 3 7
17. G. McCleane Pharmacological management of neuropathic pain CNS Drugs 17 2003 1031 1043
18. K. Meyer-Rosberg, A. Kvarnstrom, and E. Kinnman Peripheral Neuropathic Pain - a multidimensional burden for patients Eur J Pain 5 2001 379 389
19. L. Nikolajsen, and T.S. Jensen Phantom limb pain Br J Anaesth 87 2001 107 116
20. T. Nurmikko, and P. Eldridge Trigeminal neuralgia: pathophysiology, diagnosis and current treatment Br J Anaesth 87 2001 117 132
21. G. Oster, E. Dukes, G. Harding, and P. Cleary Pain, activity interference, and health perceptions in elderly persons with post-herpetic neuralgia Pain 4 Suppl. 1 2003 19
22. M. Ries, E. Mengel, and G. Kutschke Use of gabapentin to reduce chronic neuropathic pain in Fabry disease J Inherit Metab Dis 26 4 2003 413 414
23. J. Rosenstock, M. Tuchman, L. LaMoreaux, and U. Sharma Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial Pain 110 3 2004 628 638
24. M. Rowbotham, N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial JAMA 280 1998 1837 1842
25. R. Sabatowski, R. Gálvez, D.A. Cherry, F. Jacquot, E. Vincent, P. Maisonobe and the 1008-045 Study Group Pregabalin reduces pain and improves sleep and mood in patients with post-hepetic neuralgia: results of a randomised, placebo-controlled clinical trial Pain 109 2004 26 35
26. R. Serlin, T. Mendoza, Y. Nakamura, K. Edwards, and C. Cleeland When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function Pain 61 1995 277 284
27. S. Sindrup, and T. Jensen Pharmacologic treatment of pain in polyneuropathy Neurology 55 2000 915 920
28. D. Zelman, E. Dukes, N. Brandenburg, A. Bostrom, and M. Gore Classification of mild, moderate and severe pain due to diabetic peripheral neuropathy based on levels of functional disability J Pain 5 Suppl. 1 2004 114